PEAK6 Investments’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,969
Closed -$59.1K 3549
2024
Q1
$59.1K Buy
+2,969
New +$57.4K ﹤0.01% 3532
2022
Q1
Sell
-13,148
Closed -$456K 5180
2021
Q4
$456K Buy
+13,148
New +$425K ﹤0.01% 3299
2020
Q2
Sell
-10,401
Closed -$301K 4351
2020
Q1
$280K Buy
+10,401
New +$311K ﹤0.01% 2551
2019
Q1
Sell
-4,947
Closed -$222K 3798
2018
Q4
$222K Buy
+4,947
New +$259K ﹤0.01% 2956

Other funds holding AVNS

PEAK6 Investments's AVNS Position: Q2 2024 in Review

PEAK6 Investments sold out of Avanos Medical (AVNS) in Q2 2024, closing a stake of 2,969 shares — an estimated $59.1K sold.

PEAK6 Investments first reported a position in AVNS in Q4 2018 and held it in 4 quarters. The position peaked at $456K in Q4 2021. 258 funds tracked by Wall St. Rank hold AVNS as of Q2 2024.

  • PEAK6 Investments reported no remaining Avanos Medical position as of Q2 2024 after selling out during the quarter.
  • PEAK6 Investments sold 2,969 Avanos Medical shares in Q2 2024, an estimated $59.1K.
  • PEAK6 Investments first reported a position in Avanos Medical in Q4 2018 and held it in 4 quarters.
  • PEAK6 Investments's Avanos Medical position peaked at $456K in Q4 2021.
  • 258 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2024.

Based on PEAK6 Investments's 13F filing for Q2 2024, filed 14 Aug 2024.